Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 119

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six‐week placebo‐controlled, double‐blind, multicentre trial

Holtmann, G., Adam, B., Haag, S., Collet, W., Grünewald, E., Windeck, T.·2003·Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background : This study aimed to assess the efficacy of artichoke leaf extract (ALE) in the treatment of patients with functional dyspepsia (FD). Methods : In a double‐blind, randomized controlled trial (RCT), 247 patients with functional dyspepsia were recruited and treated with either a commercial ALE preparation (2 × 320 mg plant extract t.d.s.) or a placebo. The primary efficacy variable was the sum score of the patient's weekly rating of the overall change in dyspeptic symptoms (four‐point scale). Secondary variables were the scores of each dyspeptic symptom and the quality of life (QOL) as assessed by the Nepean Dyspepsia Index (NDI). Results : Two hundred and forty‐seven patients were enrolled, and data from 244 patients (129 active treatment, 115 placebo) were suitable for inclusion in the statistical analysis (intention‐to‐treat). The overall symptom improvement over the 6 weeks of treatment was significantly greater with ALE than with the placebo (8.3 ± 4.6, vs. 6.7 ± 4.8, P < 0.01). Similarly, patients treated with ALE showed significantly greater improvement in the global quality‐of‐life scores (NDI) compared with the placebo‐treated patients (− 41.1 ± 47.6 vs. − 24.8 ± 35.6, P < 0.01). Conclusion : The ALE preparation tested was significantly better than the placebo in alleviating symptoms and improving the disease‐specific quality of life in patients with functional dyspepsia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2036.2003.01767.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 22

  1. Talley NJ, 1991, Functional dyspepsia. a classification with guidelines for diagnosis and management, Gastroenterol Int, 4, 145
  2. Talley NJ, 1999, Functional gastroduodenal disorders, Gut, 45
  3. 10.1111/j.1365-2036.1995.tb00359.x · DOI
  4. 10.2165/00003495-199345060-00005 · DOI
  5. 10.1016/0016-5085(86)90451-8 · DOI
  6. 10.1046/j.1365-2036.1998.00410.x · DOI
  7. 10.1097/00004836-199806000-00022 · DOI
  8. 10.1097/00004836-198904000-00011 · DOI · Paper page
  9. 10.1016/S0002-9270(00)02314-5 · DOI
  10. 10.7326/0003-4819-134-5-200103060-00008 · DOI
  11. 10.1016/S0944-7113(11)80027-9 · DOI
  12. 10.1016/S0887-2333(97)00078-7 · DOI
  13. Gebhardt R, 1997, Inhibition of hepatic cholesterol biosynthesis by artichoke leaf extracts is mainly due to luteolin, Cell Biol Toxicol, 13, 58
  14. 10.1080/10715769800300281 · DOI
  15. 10.1080/10715760000301171 · DOI
  16. 10.1080/10715760100300741 · DOI
  17. Fintelmann V, 1998, Langzeitanwendung eines Artischocken‐Extraktes bei dyspeptischem Symptomkomplex. Ergebnisse einer Beobachtungsstudie, Naturamed, 13, 17
  18. 10.1078/094471102321621287 · DOI
  19. 10.1046/j.1365-2036.2001.00900.x · DOI
  20. 10.1046/j.1365-2036.1999.00445.x · DOI
  21. 10.1007/BF02087563 · DOI
  22. Van Zanten SJOV, 1996, Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials, Am J Gastroenterol, 91, 660

Cited by

See all 119

Metadata

Authors
Holtmann, G., Adam, B., Haag, S., Collet, W., Grünewald, E., & Windeck, T.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2003-11-20
Volume
18
Issue
11-12
Pages
1099-1105
ISSN
  • 0269-2813
  • 1365-2036
Cited by
119
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.